Skip to main content
Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
4.070
+0.050 (1.24%)
At close: Nov 22, 2024, 4:00 PM
4.060
-0.010 (-0.25%)
After-hours: Nov 22, 2024, 6:54 PM EST

Geron Revenue

Geron had revenue of $28.27M in the quarter ending September 30, 2024, with 17,138.41% growth. This brings the company's revenue in the last twelve months to $29.48M, up 9,199.68% year-over-year. In the year 2023, Geron had annual revenue of $237.00K, down -60.23%.

Revenue (ttm)
$29.48M
Revenue Growth
+9,199.68%
P/S Ratio
86.81
Revenue / Employee
$209,078
Employees
141
Market Cap
2.46B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023237.00K-359.00K-60.23%
Dec 31, 2022596.00K-797.00K-57.21%
Dec 31, 20211.39M1.14M450.59%
Dec 31, 2020253.00K-207.00K-45.00%
Dec 31, 2019460.00K-606.00K-56.85%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
TransMedics Group 401.09M
Zai Lab 355.75M
Twist Bioscience 312.97M
LeMaitre Vascular 213.03M
Janux Therapeutics 13.05M
Centessa Pharmaceuticals 6.85M
Revenue Rankings

GERN News

More News